Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

Zhang, Xiao-Hui, Tee, Louis Y, Wang, Xiao-Gang, Huang, Qun-Shan, Yang, Shi-Hua·2015·Molecular Therapy - Nucleic Acids

Cited by (1,000)

Items 201–300 of 1,000

  1. Genome Editing by CRISPR-Cas: A Game Change in the Genetic Manipulation of Chlamydomonas
    Manel Ghribi, Serge Basile Nouemssi, Fatma Meddeb‐Mouelhi, Isabel Desgagné‐Penix · 2020 · Life
  2. CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics
    Tirthankar Sen, Rajkumar P. Thummer · 2022 · Neurotoxicity Research
  3. Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine
    Ruixuan Zheng, Lexiang Zhang, Rokshana Parvin, Lihuang Su, Junjie Chi, Keqing Shi, Fangfu Ye, Xiaoying Huang · 2023 · Advanced Science
  4. Enhancing CRISPR/Cas systems with nanotechnology
    Rupali Chowdhry, Steven Z. Lu, Seungheon Lee, Shivudu Godhulayyagari, Sasha B. Ebrahimi, Devleena Samanta · 2023 · Trends in biotechnology
  5. Epigenetic editing: How cutting-edge targeted epigenetic modification might provide novel avenues for autoimmune disease therapy
    Matlock Arizona Jeffries · 2018 · Clinical Immunology
  6. Effective use of sequence information to predict CRISPR-Cas9 off-target
    Zhong-Rui Zhang, Zhenran Jiang · 2022 · Computational and Structural Biotechnology Journal
  7. Specificity of oligonucleotide gene therapy (OGT) agents
    Daria D. Nedorezova, Mikhail V. Dubovichenko, Ekaterina P. Belyaeva, Ekaterina D. Grigorieva, Arina V. Peresadina, Dmitry M. Kolpashchikov · 2022 · Theranostics
  8. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery
    Gulzar Ahmad, Mansoor M. Amiji · 2018 · Drug Discovery Today
  9. Insights into maize genome editing via CRISPR/Cas9
    Astha Agarwal, Pranjal Yadava, Krishan Kumar, Ishwar Singh, Tanushri Kaul, A. Pattanayak, Pawan Kumar Agrawal · 2018 · Physiology and Molecular Biology of Plants
  10. Base Editing: The Ever Expanding Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Tool Kit for Precise Genome Editing in Plants
    Mahmuda Binte Monsur, Gaoneng Shao, Yusong Lv, Shakeel Ahmad, Xiangjin Wei, Peisong Hu, Shaoqing Tang · 2020 · Genes
  11. Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management
    Khaled S. Allemailem, Mohammed A. Alsahli, Ahmad Almatroudi, Faris Alrumaihi, Waleed Al Abdulmonem, Amira A. Moawad, Wanian M Alwanian, Nahlah Makki Almansour, Arshad Husain Rahmani, Amjad Ali Khan · 2023 · International Journal of Nanomedicine
  12. Development of a CRISPR/Cas9-Based Tool for Gene Deletion in Issatchenkia orientalis
    Vinh Gia Tran, Mingfeng Cao, Zia Fatma, Xiaofei Song, Huimin Zhao · 2019 · mSphere
  13. CRISPR/Cas9 Genome Editing Introduction and Optimization in the Non-model Insect Pyrrhocoris apterus
    Joanna Kotwica‐Rolinska, Lenka Chodáková, Daniela Chvalová, Lucie Krištofová, Iva Fenclova, Jan Provazník, Maly Bertolutti, Bulah Chia-hsiang Wu, David Doležel · 2019 · Frontiers in Physiology
  14. CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
    Sadegh Shojaei Baghini, Zhanna R. Gardanova, Saeme Azizi Hassan Abadi, Burhan Abdullah Zaman, Ahmet İlhan, Navid Shomali, Ali Adili, Roozbeh Moghaddar, Amirhossein Fakhre Yaseri · 2022 · Cellular & Molecular Biology Letters
  15. Application and perspective of CRISPR/Cas9 genome editing technology in human diseases modeling and gene therapy
    Manling Zhang, Hongbin Li, Yong Jin · 2024 · Frontiers in Genetics
  16. CRISPR/Cas system: A game changing genome editing technology, to treat human genetic diseases
    Wajid Hussain, Tariq Mahmood, Jawad S. Hussain, Niyaz Ali, Tariq Mahmud Shah, Sadia Qayyum, Ibrar Khan · 2018 · Gene
  17. Programmable Molecular Scissors: Applications of a New Tool for Genome Editing in Biotech
    Subbroto Kumar Saha, Forhad Karim Saikot, Md. Shahedur Rahman, Mohammad Abu Hena Mostofa Jamal, S.M. Khaledur Rahman, S. M. Riazul Islam, Ki‐Hyun Kim · 2018 · Molecular Therapy — Nucleic Acids
  18. Multifunctional Delivery Systems for Peptide Nucleic Acids
    Stefano Volpi, Umberto Cancelli, Martina Neri, Roberto Corradini · 2020 · Pharmaceuticals
  19. Machine learning applications for therapeutic tasks with genomics data
    Kexin Huang, Cao Xiao, Lucas M. Glass, Cathy W. Critchlow, Greg C. Gibson, Jimeng Sun · 2021 · Patterns
  20. Monolignol acyltransferase for lignin p-hydroxybenzoylation in Populus
    Yunjun Zhao, Xiaohong Yu, Pui Ying Lam, Kewei Zhang, Yuki Tobimatsu, Chang‐Jun Liu · 2021 · Nature Plants
  21. High-throughput single-molecule telomere characterization
    Jennifer McCaffrey, ELEANOR A. YOUNG, Katy A. Lassahn, Justin G. Sibert, Steven J. Pastor, Harold C. Riethman, Ming Xiao · 2017 · Genome Research
  22. AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model
    Marika Marino, Lujia Zhou, Melvin Y. Rincón, Zsuzsanna Callaerts‐Vegh, Jens Verhaert, Jérôme Wahis, Eline Creemers, Lidia Yshii, Keimpe D. B. Wierda, Takashi Saito et al. · 2022 · EMBO Molecular Medicine
  23. Techniques for assessing telomere length: A methodological review
    Hyeon Jong Yu, Yoon Hwan Byun, Chul‐Kee Park · 2024 · Computational and Structural Biotechnology Journal
  24. The Ethics of Human Embryo Editing via CRISPR-Cas9 Technology: A Systematic Review of Ethical Arguments, Reasons, and Concerns
    Lindsay Wiley, Mattison Cheek, Emily LaFar, Xiaolu Ma, Justin Sekowski, Nikki Tanguturi, Ana S. Iltis · 2024 · HEC Forum
  25. Combined shRNA over CRISPR/cas9 as a methodology to detect off-target effects and a potential compensatory mechanism
    Liat Peretz Zats, Elazar Besser, Renana Hajbi, Natania Casden, Dan Ziv, Nechama Kronenberg, Liat Ben-Gigi, Sahar Sweetat, Saleh Khawaled, Rami Aqeilan et al. · 2018 · Scientific Reports
  26. Metabolic engineering of Saccharomyces cerevisiae using the CRISPR/Cas9 system to minimize ethyl carbamate accumulation during Chinese rice wine fermentation
    Dianhui Wu, Wenjuan Xie, Xiaomin Li, Guolin Cai, Jian Zhang Lu, Guangfa Xie · 2020 · Applied Microbiology and Biotechnology
  27. Development of a pVEC peptide-based ribonucleoprotein (RNP) delivery system for genome editing using CRISPR/Cas9 in Chlamydomonas reinhardtii
    Seongsu Kang, Seungjib Jeon, Seungcheol Kim, Yong Keun Chang, Yeu‐Chun Kim · 2020 · Scientific Reports
  28. Synergizing Off-Target Predictions for In Silico Insights of CENH3 Knockout in Cannabis through CRISPR/Cas
    Mohsen Hesami, Mohsen Yoosefzadeh-Najafabadi, Kristian Adamek, Davoud Torkamaneh, Andrew Maxwell Phineas Jones · 2021 · Molecules
  29. Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquito
    William T. Garrood, Nace Kranjc, Karl Petri, Daniel Y. Kim, Jimmy A. Guo, Andrew Hammond, Ioanna Morianou, Vikram Pattanayak, J. Keith Joung, Andrea Crisanti et al. · 2021 · Proceedings of the National Academy of Sciences
  30. Gene therapy for Fabry disease: Progress, challenges, and outlooks on gene-editing
    Jakob M. Domm, Sarah K. Wootton, Jeffrey A. Medin, Michael L. West · 2021 · Molecular Genetics and Metabolism
  31. The promise of explainable deep learning for omics data analysis: Adding new discovery tools to AI
    Mariangela Santorsola, Francesco Lescai · 2023 · New Biotechnology
  32. CRISPR-Cas System: The Current and Emerging Translational Landscape
    Narendranath Bhokisham, Ethan Laudermilch, Lindsay L. Traeger, Tonya D. Bonilla, Mercedes Ruíz-Estévez, Jordan R. Becker · 2023 · Cells
  33. CRISPR/Cas9 gene editing in a chicken model: current approaches and applications
    Luiza Chojnacka-Puchta, Dorota Sawicka · 2020 · Journal of Applied Genetics
  34. CRISPR /Cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunity
    Iraj Mohammadzadeh, Durdi Qujeq, Tooba Yousefi, Gordon A. Ferns, Mahmood Maniati, Mostafa Vaghari‐Tabari · 2020 · IUBMB Life
  35. Orthogonal arrays of particle assembly are essential for normal aquaporin‐4 expression level in the brain
    Manuela De Bellis, Antonio Cibelli, Maria Grazia Mola, Francesco Pisani, Barbara Barile, Maria Mastrodonato, Shervin Banitalebi, Mahmood Reza Amiry-Moghaddam, Pasqua Abbrescia, Antonio Frigeri et al. · 2020 · Glia
  36. State‐of‐the‐art therapies for Rett syndrome
    Nicolas Panayotis, Yann Ehinger, Marie‐Solenne Félix, Jean‐Christophe Roux · 2022 · Developmental Medicine & Child Neurology
  37. Prime editing: Mechanism insight and recent applications in plants
    Tien Van Vu, Ngan Thi Nguyen, Jihae Kim, Jong Chan Hong, Jae‐Yean Kim · 2023 · Plant Biotechnology Journal
  38. CRISPR-Cas9 System Mediated Genome Editing Technology: An Ultimate Tool to Enhance Abiotic Stress in Crop Plants
    Heba Ibrahim Mohamed, Ayesha Rashid Khan, Abdul Basıt · 2024 · Journal of soil science and plant nutrition
  39. Enhancing Specificity, Precision, Accessibility, Flexibility, and Safety to Overcome Traditional CRISPR/Cas Editing Challenges and Shape Future Innovations
    Muna Alariqi, Mohamed Ramadan, Lu Yu, Fengjiao Hui, Amjad Hussain, Xiaofeng Zhou, Yu Yu, Xianlong Zhang, Shuangxia Jin · 2025 · Advanced Science
  40. Novel genetic therapeutic approaches for modulating the severity of β‑thalassemia (Review)
    Fareeha Amjad, Tamseel Fatima, Tuba Fayyaz, Muhammad Jawad Khan, Muhammad Imran Qadeer · 2020 · Biomedical Reports
  41. C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy
    Bing-Ru Yan, Taoyingnan Li, Étienne Coyaud, Estelle M. N. Laurent, Jonathan R. St‐Germain, Yuhuan Zhou, Peter Kijun Kim, Brian Raught, John Hunter Brumell · 2021 · Autophagy
  42. The promise of CRISPR/Cas9 technology in diabetes mellitus therapy: How gene editing is revolutionizing diabetes research and treatment
    Yan Cheng, Haiyang Wang, Mo Li · 2023 · Journal of Diabetes and its Complications
  43. Unlocking Fungal Potential: The CRISPR-Cas System as a Strategy for Secondary Metabolite Discovery
    Karla Leal, Edwind Rojas, David Madariaga-Troncoso, María José Contreras, Kattia Núñez-Montero, Leticia Barrientos, Olman Gómez-Espinoza, Isabel Iturrieta‐González · 2024 · Journal of Fungi
  44. Photoactivatable Engineering of CRISPR/Cas9‐Inducible DNAzyme Probe for In Situ Imaging of Nuclear Zinc Ions
    Ran Liu, Difei Jiang, Yangfang Yun, Zhe Feng, Fenfen Zheng, Yu Xiang, Huanhuan Fan, Jingjing Zhang · 2024 · Angewandte Chemie International Edition
  45. Whole-genome sequencing reveals highly specific gene targeting by in vitro assembled Cas9-ribonucleoprotein complexes in Aspergillus fumigatus
    Qusai Al Abdallah, Ana Camila Oliveira Souza, Adela Martín‐Vicente, Wenbo Ge, Jarrod R. Fortwendel · 2018 · Fungal Biology and Biotechnology
  46. Expanding Gene-Editing Potential in Crop Improvement with Pangenomes
    Cassandria G. Tay Fernandez, Benjamin John Nestor, Monica F. Danilevicz, Jacob Ian Marsh, Jakob Petereit, Philipp E. Bayer, Jacqueline Batley, David Edwards · 2022 · International Journal of Molecular Sciences
  47. Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing
    Eric Alves, Shahama Taifour, Riccardo Dolcetti, Jonathan Chee, Anna K. Nowak, Silvana Gaudieri, Pilar Blancafort · 2021 · Molecular Therapy — Methods & Clinical Development
  48. Seizing the Hidden Assassin: Current Detection Strategies for Staphylococcus aureus and Methicillin-Resistant S. aureus
    Qi Wang, Qingli Yang · 2024 · Journal of Agricultural and Food Chemistry
  49. Advancing anticancer drug development: Overcoming challenges and exploring new therapeutic strategies
    Sachin Sharma, Chirag Kumar, Himanshu Kushwaha, Sahil, Sudhanshu Kumar Jha, Shivani Chawla, Alka Sharma, Tushar Midha, Vitthal G. Huddar · 2025 · Ayush journal of integrative oncology.
  50. Epigenetic Footprints of CRISPR/Cas9-Mediated Genome Editing in Plants
    Jun Hyung Lee, Mitra Mazarei, Alexander C. Pfotenhauer, Aubrey B. Dorrough, Magen R. Poindexter, Tarek Hewezi, Scott C. Lenaghan, David E. Graham, C. Neal Stewart · 2020 · Frontiers in Plant Science
  51. An Update on Molecular Tools for Genetic Engineering of Actinomycetes—The Source of Important Antibiotics and Other Valuable Compounds
    Lena Mitousis, Yvonne Thoma, Ewa Maria Musiol-Kroll · 2020 · Antibiotics
  52. Development of an in vivo delivery system for CRISPR/Cas9-mediated targeting of hepatitis B virus cccDNA
    Mohammad Enamul Hoque Kayesh, Yutaka Amako, Md Abul Hashem, Shuko Murakami, Shintaro Ogawa, Naoki Yamamoto, Tatsuro Hifumi, Noriaki Miyoshi, Masaya Sugiyama, Yasuhito Tanaka et al. · 2020 · Virus Research
  53. The Model System Saccharomyces cerevisiae Versus Emerging Non-Model Yeasts for the Production of Biofuels
    Maria Priscila Franco Lacerda, Eun Joong Oh, Carrie A. Eckert · 2020 · Life
  54. Hematopoietic Stem Cell-Targeted Gene-Addition and Gene-Editing Strategies for β-hemoglobinopathies
    Claire M. Drysdale, Tina Nassehi, Jackson Gamer, Morgan Yapundich, John F. Tisdale, Naoya Uchida · 2021 · Cell stem cell
  55. A neomorphic variant in SP7 alters sequence specificity and causes a high-turnover bone disorder
    Julian C. K. Lui, Adalbert Raimann, Hironori Hojo, Lijin Dong, Paul Roschger, Bijal Kikani, Uwe Wintergerst, Nadja Fratzl‐Zelman, Youn Hee Jee, Gabriele Haeusler et al. · 2022 · Nature Communications
  56. Reduction of Kaposi’s Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene
    For Yue Tso, John T. West, Charles A. Wood · 2019 · Journal of Virology
  57. The zebrafish orthologue of familial Alzheimer’s disease gene PRESENILIN 2 is required for normal adult melanotic skin pigmentation
    Haowei Jiang, Morgan Newman, Michael T. Lardelli · 2018 · PLoS ONE
  58. Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency
    Cheng-Han Chung, Alexander G. Allen, Neil T. Sullivan, Andrew Atkins, Michael R. Nonnemacher, Brian L. Wigdahl, Will Dampier · 2019 · Molecular Therapy
  59. Yeast bioprospecting versus synthetic biology—which is better for innovative beverage fermentation?
    Lucien Alperstein, Jennifer M. Gardner, Joanna F. Sundstrom, Krista M. Sumby, Vladimir Jiranek · 2020 · Applied Microbiology and Biotechnology
  60. Allele-specific genome targeting in the development of precision medicine
    Junjiao Wu, Beisha Tang, Yu Tang · 2020 · Theranostics
  61. CRISPR-Cas Genome Editing Technique for Fish Disease Management: Current Study and Future Perspective
    Md Akib Ferdous, Sk Injamamul Islam, Nasim Habib, Mazen Mohammed Almehmadi, Mamdouh A. Allahyani, Ahad Amer Alsaiari, Alaa Shafie · 2022 · Microorganisms
  62. Reference Materials for Improving Reliability of Multiomics Profiling
    Luyao Ren, Leming M. Shi, Yuanting Zheng · 2024 · Phenomics
  63. Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging
    Ibrahim A. Alradwan, Nojoud AL Fayez, Mohammad N. Alomary, Abdullah Awad Alshehri, Alhassan H. Aodah, Fahad A. Almughem, Khulud A. Alsulami, Ahmad M. Aldossary, Abdullah O. Alawad, Yahya M. K. Tawfik et al. · 2024 · Pharmaceutics
  64. Gene therapies for transfusion dependent β‐thalassemia: Current status and critical criteria for success
    Sandeep Soni · 2020 · American Journal of Hematology
  65. Advances in CRISPR Delivery Methods: Perspectives and Challenges
    Selami Demirci, Khaled Essawi, Paula Germino-Watnick, Xiong Liu, Waleed Hakami, John F. Tisdale · 2022 · The CRISPR Journal
  66. AI-Based solutions for current challenges in regenerative medicine
    Pedram Asadi Sarabi, Mahshid Shabanpouremam, Amir Reza Eghtedari, Mahsa Barat, Behzad Moshiri, Ali Zarrabi, Massoud Vosough · 2024 · European Journal of Pharmacology
  67. Detection of genome edits in plants—from editing to seed
    Raymond D. Shillito, Sherry R. Whitt, Margit Ross, Farhad Ghavami, David De Vleesschauwer, Katelijn D’Halluin, Annelies Van Hoecke, Frank Meulewaeter · 2021 · In Vitro Cellular & Developmental Biology - Plant
  68. Induced Pluripotent Stem Cells (iPSCs) and Gene Therapy: A New Era for the Treatment of Neurological Diseases
    Giulia Paolini Sguazzi, Valentina Muto, Marco Tartaglia, Enrico Bertini, Claudia Compagnucci · 2021 · International Journal of Molecular Sciences
  69. Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation
    Denis N. Silachev, Alexey Koval, Mikhail Savitsky, Guru Prasad Padmasola, Charles Quairiaux, Fabrizio Thorel, Vladimir L. Katanaev · 2022 · Acta Neuropathologica Communications
  70. Emerging Gene Therapeutics for Epidermolysis Bullosa under Development
    Johannes Bischof, Markus Hierl, Ulrich Koller · 2024 · International Journal of Molecular Sciences
  71. Optimizing cancer treatment: the synergistic potential of CAR-T cell therapy and CRISPR/Cas9
    Maryam Amiri, Amir Kian Moaveni, Masoumeh Majidi Zolbin, Behrouz Shademan, Alireza Nourazarian · 2024 · Frontiers in Immunology
  72. Genome editing in maize and sorghum: A comprehensive review of CRISPR/Cas9 and emerging technologies
    Mercy Jocyline Namata, Jingyi Xu, Ephrem Habyarimana, Sudhakar Reddy Palakolanu, Lihua Wang, Jieqin Li · 2025 · The Plant Genome
  73. A detailed cell-free transcription-translation-based assay to decipher CRISPR protospacer-adjacent motifs
    Colin S. Maxwell, Thomas L. Jacobsen, Ryan Marshall, Vincent Noireaux, Chase L. Beisel · 2018 · Methods
  74. Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy
    Carla Sanjurjo-Soriano, Vasiliki Kalatzis · 2018 · Neural Plasticity
  75. A new level of complexity in parasite-host interaction: The role of extracellular vesicles
    Maibritt Mardahl, Anne Borup, Peter Lindberg Nejsum · 2019 · Advances in Parasitology/Advances in parasitology
  76. CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering
    Katja Glinšek, Krištof Bozovičar, Tomaž Bratkovič · 2023 · International Journal of Molecular Sciences
  77. Gene editing tools: state-of-the-art and the road ahead for the model and non-model fishes
    Hirak Kumar Barman, Kiran Dashrath Rasal, Vemulawada Chakrapani, Arun S. Ninawe, Doyil T. Vengayil, Syed Asrafuzzaman, Jitendra Kumar Sundaray, Pallipuram Jayasankar · 2017 · Transgenic Research
  78. Editing of StSR4 by Cas9-RNPs confers resistance to Phytophthora infestans in potato
    Ki-Beom Moon, Sujin Park, Ji-Sun Park, Hyo‐Jun Lee, Seung Young Shin, Soo Min Lee, Gyung Ja Choi, Sang‐Gyu Kim, Hye Sun Cho, Jae-Heung Jeon et al. · 2022 · Frontiers in Plant Science
  79. Photosynthesis: Genetic Strategies Adopted to Gain Higher Efficiency
    Naveed Khan, Seok‐Hyun Choi, Choon-Hwan Lee, Mingnan Qu, Jong‐Seong Jeon · 2024 · International Journal of Molecular Sciences
  80. From foe to friend: Rewiring oncogenic pathways through artificial selenoprotein to combat immune-resistant tumor
    Weiming You, Zheng‐Jun Zhou, Zhanfeng Li, Jin Yan, Yang Wang · 2025 · Journal of Pharmaceutical Analysis
  81. Protein Engineering Strategies to Expand CRISPR-Cas9 Applications
    Lucas F. Ribeiro, Liliane Fraga Costa Ribeiro, Matheus Quintana Barreto, Richard John Ward · 2018 · International Journal of Genomics
  82. Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9
    Dmitry S. Kostyushev, Anastasiya Kostyusheva, Sergey Brezgin, N. I. Ponomareva, Natalia F. Zakirova, Aleksandra Yu. Egorshina, Dmitry V. Yanvarev, Баюрова Екатерина Олеговна, Anna Sudina, Irina A. Goptar et al. · 2023 · Molecular Therapy — Nucleic Acids
  83. Functional interrogation of non-coding DNA through CRISPR genome editing
    Matthew C. Canver, Daniel E. Bauer, Stuart H. Orkin · 2017 · Methods
  84. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies
    Jian Tu, Zijun Huo, Yao Yu, Dandan Zhu, An Xu, Mo-Fan Huang, Ruifeng Hu, Ruoyu Wang, Julian A. Gingold, Yi‐Hung Chen et al. · 2022 · Proceedings of the National Academy of Sciences
  85. Recent Updates of the CRISPR/Cas9 Genome Editing System: Novel Approaches to Regulate Its Spatiotemporal Control by Genetic and Physicochemical Strategies
    Khaled S. Allemailem, Ahmad Almatroudi, Arshad Husain Rahmani, Faris Alrumaihi, Arwa Essa Alradhi, Amal Al-Subaiyel, Mohammad Algahtani, Rand Mohammad Almousa, Ali Mahzari, Abdulmajeed Abdulghani A. Sindi et al. · 2024 · International Journal of Nanomedicine
  86. Efficient Genome Editing in Chicken DF-1 Cells Using the CRISPR/Cas9 System
    Yichun Bai, Linjie He, Pengcheng Li, Kun Xu, Simin Shao, Chonghua Ren, Zhongtian Liu, Zehui Wei, Zhiying Zhang · 2016 · G3 Genes Genomes Genetics
  87. Aryl hydrocarbon receptor counteracts pharmacological efficacy of doxorubicin via enhanced AKR1C3 expression in triple negative breast cancer cells
    Naoya Yamashita, Yuichiro Kanno, Nao Saito, Kensuke Terai, Noriko Sanada, Ryoichi Kizu, Nobuyuki Hiruta, Youngjin Park, Hideaki Bujo, Kiyomitsu Nemoto · 2019 · Biochemical and Biophysical Research Communications
  88. The AKR1B1 inhibitor epalrestat suppresses the progression of cervical cancer
    Jie Ji, Minxue Xu, Tianyang Qian, Shengze Zhu, Feng Jiang, Zhao-Xiu Liu, Weisong Xu, Juan Zhou, Mingbing Xiao · 2020 · Molecular Biology Reports
  89. Challenges of CRISPR-Based Gene Editing in Primary T Cells
    Alaleh Rezalotfi, Lea V. Fritz, Reinhold Förster, Berislav Bošnjak · 2022 · International Journal of Molecular Sciences
  90. RAISING is a high-performance method for identifying random transgene integration sites
    Yusaku Wada, Tomoo Sato, Hiroo Hasegawa, Takahiro Matsudaira, Naganori Nao, Ariella L. G. Coler-Reilly, Tomohiko Tasaka, Shunsuke Yamauchi, Tomohiro Okagawa, Haruka Momose et al. · 2022 · Communications Biology
  91. An Updated Overview on Insights into Sugarcane Genome Editing via CRISPR/Cas9 for Sustainable Production
    Shareif Hammad Hussin, Xinlong Liu, Chunjia Li, Mohamed Diaby, Ghulam Hussain Jatoi, Raees Ahmed, Muhammad Imran, Muhammad Aamir Iqbal · 2022 · Sustainability
  92. CRISPR/Cas9—Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development
    Arinze Stanley Okoli, Malachy Ifeanyi Okeke, Morten Tryland, Ugo Lionel Moens · 2018 · Viruses
  93. Endogenous circadian reporters reveal functional differences of PERIOD paralogs and the significance of PERIOD:CK1 stable interaction
    Jiyoung Park, Kwangjun Lee, Hyeongseok Kim, Heungsop Shin, Choogon Lee · 2023 · Proceedings of the National Academy of Sciences
  94. A versatile CRISPR/Cas9 system off-target prediction tool using language model
    Weian Du, Liang Zhao, Kaichuan Diao, Yangyang Zheng, Qianyong Yang, Zhenzhen Zhu, Xiangxing Zhu, Dongsheng Tang · 2025 · Communications Biology
  95. CRISPR/Cas9-mediated gene replacement in the basidiomycetous yeast Pseudozyma antarctica
    Emi Kunitake, Takumi Tanaka, Hirokazu Ueda, Akira Endo, Tohru Yarimizu, Etsuko Katoh, Hiroko Kuze Kitamoto · 2019 · Fungal Genetics and Biology
  96. CReasPy-Cloning: A Method for Simultaneous Cloning and Engineering of Megabase-Sized Genomes in Yeast Using the CRISPR-Cas9 System
    Estelle Ruiz, Vincent Talenton, Marie-Pierre Dubrana, Gabrielle Guesdon, María Lluch‐Senar, Franck Salin, Pascal Sirand‐Pugnet, Yonathan Arfi, Carole Lartigue · 2019 · ACS Synthetic Biology
  97. A CRISPRi-dCas9 System for Archaea and Its Use To Examine Gene Function during Nitrogen Fixation by Methanosarcina acetivorans
    Ahmed E. Dhamad, Daniel J. Lessner · 2020 · Applied and Environmental Microbiology
  98. CRISPR-Cas systems: Challenges and future prospects
    Nisarg Gohil, Gargi Bhattacharjee, Navya Lavina Lam, Samuel David Perli, Vijai Singh · 2021 · Progress in molecular biology and translational science
  99. Modern Genome Editing Technologies in Huntington’s Disease Research
    Tuyana B. Malankhanova, Anastasia A. Malakhova, Sergey P. Medvedev, Suren M. Zakian · 2017 · Journal of Huntington s Disease
  100. A permutation-based non-parametric analysis of CRISPR screen data
    Gaoxiang Jia, Xinlei Wang, Guanghua Xiao · 2017 · BMC Genomics